The New York Times @nytimes
An FDA panel is set to begin two days of meetings that are expected to strongly influence whether at least some recipients of the Moderna and Johnson & Johnson Covid vaccines should get booster shots. https://t.co/Lp2Bvw6Idw — PolitiTweet.org